Why We Exist
Society is facing a metabolic health crises.
If nothing is done, we risk creating a world where illness and suffering overshadow human progress and achievements.
BioCoach aims to provide the tools and resources to take control of their metabolic health.
BioCoach's approach to health is unique, in that we focus on improving your metabolic health through personalized lifestyle coaching, data-driven insights, and cutting-edge biotechnology.
At BioCoach, we combine the power of advanced diagnostics, nutrition, exercise, and stress management to optimize an individual's overall well-being.
BioCoach was originally founded as KetoCoach in 2018 by Matt Payne as a ketogenic diet tech company focusing on monitoring blood ketone levels. In 2020, KetoCoach launched our FastCoach app which supported intermittent fasting with tools like our fasting timer and challenges to help hold participants accountable.
In 2021, we were struck by the many success stories we heard from individuals with metabolic disregulation using a low carb diet to manage their condition, including stories from individuals using our device and our app. This prompted us to take a closer look at diabetes and prediabetes and we were blown away by what we saw.
Diabetes is now the 7th leading cause of death in the United States. Over 13% of the adult population is suffering from diabetes(*) and the number has continued to grow over the last 4 decades. In 1980, there were 108 million adults suffering from diabetes globally, today that number has risen to well over 400 million.
Even worse than the prevalence of diabetes is the rapid increase in rates of prediabetes. Today it is estimated that 1/3 of U.S. adults suffer from prediabetes and nearly 89% are metabolically unhealthy, meaning even more people are on the fast track to prediabetes, diabetes, and the many other chronic diseases that often accompany these disorders.
The burden of diabetes is not just on the individual suffering from the disease, it is also on our society and economy as a whole.
Diagnosed diabetes in the U.S. costs well over $300 billion annually with diagnosed diabetics accruing over 2.3x the medical costs of non-diabetics. The dagger is that with standard diabetic treatment, the patient is rarely cured and often develops secondary and tertiary health complications.